NO137550C - Analogifremgangsmaate til fremstilling av anti-inflammatorisk virksomme 2,4,5-trisubstituerte oksazolforbindelser - Google Patents

Analogifremgangsmaate til fremstilling av anti-inflammatorisk virksomme 2,4,5-trisubstituerte oksazolforbindelser

Info

Publication number
NO137550C
NO137550C NO4068/72A NO406872A NO137550C NO 137550 C NO137550 C NO 137550C NO 4068/72 A NO4068/72 A NO 4068/72A NO 406872 A NO406872 A NO 406872A NO 137550 C NO137550 C NO 137550C
Authority
NO
Norway
Prior art keywords
oxsazole
trisubstituted
compounds
preparation
inflammatory active
Prior art date
Application number
NO4068/72A
Other languages
English (en)
Norwegian (no)
Other versions
NO137550B (no
Inventor
Giorgio Tarzia
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of NO137550B publication Critical patent/NO137550B/no
Publication of NO137550C publication Critical patent/NO137550C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO4068/72A 1972-08-07 1972-11-09 Analogifremgangsmaate til fremstilling av anti-inflammatorisk virksomme 2,4,5-trisubstituerte oksazolforbindelser NO137550C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2795872 1972-08-07

Publications (2)

Publication Number Publication Date
NO137550B NO137550B (no) 1977-12-05
NO137550C true NO137550C (no) 1978-03-15

Family

ID=11222675

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4068/72A NO137550C (no) 1972-08-07 1972-11-09 Analogifremgangsmaate til fremstilling av anti-inflammatorisk virksomme 2,4,5-trisubstituerte oksazolforbindelser

Country Status (23)

Country Link
JP (1) JPS5030619B2 (xx)
KR (1) KR780000069B1 (xx)
AR (1) AR200007A1 (xx)
AT (1) AT322551B (xx)
AU (1) AU477231B2 (xx)
BE (1) BE794096A (xx)
CH (1) CH544105A (xx)
CS (1) CS177127B2 (xx)
DD (1) DD106387A5 (xx)
DE (1) DE2301030A1 (xx)
ES (1) ES417638A1 (xx)
FR (1) FR2195430B1 (xx)
GB (1) GB1374345A (xx)
HU (1) HU164781B (xx)
IE (1) IE36941B1 (xx)
IL (1) IL40904A (xx)
LU (1) LU66643A1 (xx)
NL (1) NL149797B (xx)
NO (1) NO137550C (xx)
RO (1) RO63442A (xx)
SE (1) SE376236B (xx)
SU (1) SU511003A3 (xx)
ZA (1) ZA728259B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD112905A5 (xx) * 1971-09-02 1975-05-12 Snam Progetti
US4110256A (en) * 1976-06-22 1978-08-29 Nippon Soken, Inc. Catalyst for reforming fuel and method for producing same
JPS59125900U (ja) * 1983-02-10 1984-08-24 マルヤス機械株式会社 組立ライン装置
DE3425118A1 (de) * 1984-07-07 1986-01-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue redox-indikatoren
JPS6133499U (ja) * 1984-07-30 1986-02-28 中西金属工業株式会社 電気製品製造用パレツト
ES2144403T3 (es) * 1990-11-30 2000-06-16 Otsuka Pharma Co Ltd Derivados de tiazol como inhibidores de oxigeno activo.
GB0709031D0 (en) 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
US8946231B2 (en) 2009-03-23 2015-02-03 Merck Sharp & Dohme Corp. P2X3, receptor antagonists for treatment of pain
GB201202027D0 (en) 2012-02-06 2012-03-21 Sareum Ltd Pharmaceutical compounds
US20130231340A1 (en) 2012-03-02 2013-09-05 Sareum Limited Pharmaceutical compounds
GB201617871D0 (en) 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226548A (xx) * 1967-06-14 1971-03-31 Wyeth John & Brother Ltd

Also Published As

Publication number Publication date
RO63442A (fr) 1978-07-15
JPS5030619B2 (xx) 1975-10-02
SE376236B (xx) 1975-05-12
IE36941B1 (en) 1977-03-30
IE36941L (en) 1974-02-07
AR200007A1 (es) 1974-10-15
DE2301030A1 (de) 1974-02-28
AU5698273A (en) 1974-12-19
AU477231B2 (en) 1976-10-21
IL40904A0 (en) 1973-01-30
ZA728259B (en) 1973-07-25
CH544105A (fr) 1973-11-15
FR2195430B1 (xx) 1976-04-09
IL40904A (en) 1975-12-31
NL7300326A (xx) 1974-02-11
KR780000069B1 (en) 1978-03-30
SU511003A3 (ru) 1976-04-15
NL149797B (nl) 1976-06-15
JPS4945067A (xx) 1974-04-27
DD106387A5 (xx) 1974-06-12
BE794096A (fr) 1973-05-16
AT322551B (de) 1975-05-26
HU164781B (xx) 1974-04-11
ES417638A1 (es) 1976-02-01
CS177127B2 (xx) 1977-07-29
FR2195430A1 (xx) 1974-03-08
LU66643A1 (xx) 1973-02-14
NO137550B (no) 1977-12-05
GB1374345A (en) 1974-11-20

Similar Documents

Publication Publication Date Title
NO136298C (no) Analogifremgangsm}te til fremstilling av antibakterielt virksomme imidazolderivater
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO136094C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive d-1-(4-amino-fenyl)-2-alkylamino-etanol-derivater.
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO740606L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser.
NO137966C (no) Analogifremgangsmaate til fremstilling av antibakterielt virksomme 5-oksopyrido-(2,3-d)-pyrimidinderivater
NO137550C (no) Analogifremgangsmaate til fremstilling av anti-inflammatorisk virksomme 2,4,5-trisubstituerte oksazolforbindelser
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO140858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
NO740607L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser.
SE420603B (sv) Forfarande for framstellning av metyl-3-(2-kinoxolinylmetylen)-karbazat-n?721, n?724-dioxid
SE388611B (sv) Analogiforfarande for framstellning av 1,4-bensodiazeponderivat
NO138659C (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive, nye 3,5-disubstituerte triazolforbindelser
NO136410C (no) Analogifremgangsm}te til fremstilling av antidiabetisk virksomme 3-metyl-pyrazol-5-karboksamider.
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
NO139173C (no) Analogifremgangsmaate for fremstilling av antimikrobielt aktive 2-kinoksalin-karboksamid-1,4-dioksyder
DK132831C (da) Analogifremgangsmade til fremstilling af 17beta-hydroxy-2,2,17-trimethyl-4-androsten-3-on
SE403613B (sv) Analogiforfarande for framstellning av vissa angivna 3,4,5-trimetoxiacetofenonoximkarbamatderivat